Menu

rss
Gut 62:653 doi:10.1136/gutjnl-2012-303660
  • PostScript
  • Letter

Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease

  1. Alexander Charles Ford1,2
  1. 1Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK
  2. 2Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK
  1. Correspondence to Dr Alexander Charles Ford, Leeds Gastroenterology Institute, Room 125, 4th Floor, Bexley Wing, St. James's University Hospital, Beckett Street, Leeds LS9 7TF, UK; alexf12399{at}yahoo.com
  • Accepted 3 September 2012
  • Published Online First 27 September 2012

We read the article by Sands et al1 with interest. The efficacy of granulocyte/monocyte apheresis (GMA) in inflammatory bowel disease (IBD) is controversial, with previous studies mainly conducted in Japan, involving small numbers of patients, often without sham controls.2–4 The authors should, therefore, be congratulated for performing a large, randomised, double-blind, sham-controlled study of GMA in moderate to severely active Crohn's disease in a Western population.

The …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. gutjnl-2012-303660v1
    2. 62/4/653 most recent

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.